INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 110 filers reported holding INSYS THERAPEUTICS INC NEW in Q1 2018. The put-call ratio across all filers is 1.90 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $15,000 | +36.4% | 3,200 | 0.0% | 0.00% | – |
| Q4 2018 | $11,000 | -65.6% | 3,200 | 0.0% | 0.00% | – |
| Q3 2018 | $32,000 | +39.1% | 3,200 | 0.0% | 0.00% | – |
| Q2 2018 | $23,000 | +21.1% | 3,200 | 0.0% | 0.00% | – |
| Q1 2018 | $19,000 | -38.7% | 3,200 | 0.0% | 0.00% | – |
| Q4 2017 | $31,000 | +10.7% | 3,200 | 0.0% | 0.00% | – |
| Q3 2017 | $28,000 | -30.0% | 3,200 | 0.0% | 0.00% | – |
| Q2 2017 | $40,000 | +21.2% | 3,200 | 0.0% | 0.00% | – |
| Q1 2017 | $33,000 | +10.0% | 3,200 | 0.0% | 0.00% | – |
| Q4 2016 | $30,000 | -60.5% | 3,200 | -50.0% | 0.00% | – |
| Q3 2016 | $76,000 | +85.4% | 6,400 | +100.0% | 0.00% | – |
| Q2 2016 | $41,000 | -19.6% | 3,200 | 0.0% | 0.00% | – |
| Q1 2016 | $51,000 | -44.6% | 3,200 | 0.0% | 0.00% | – |
| Q4 2015 | $92,000 | +1.1% | 3,200 | 0.0% | 0.00% | – |
| Q3 2015 | $91,000 | -27.8% | 3,200 | -9.0% | 0.00% | – |
| Q2 2015 | $126,000 | +23.5% | 3,518 | +99.1% | 0.00% | – |
| Q1 2015 | $102,000 | +1357.1% | 1,767 | +958.1% | 0.00% | – |
| Q4 2014 | $7,000 | – | 167 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 8,912,072 | $142,504,000 | 2.66% |
| Antipodean Advisors LLC | 342,294 | $5,473,000 | 2.48% |
| JW Asset Management, LLC | 221,538 | $3,542,000 | 2.31% |
| Parametrica Management Ltd | 33,562 | $537,000 | 1.92% |
| 12 West Capital Management LP | 623,791 | $9,974,000 | 1.39% |
| Folger Hill Asset Management LP | 1,418,138 | $22,676,000 | 1.27% |
| Bellevue Group AG | 281,000 | $4,493,000 | 0.82% |
| Plymouth Lane Capital Management, LLC | 55,300 | $884,000 | 0.78% |
| Orbimed Advisors | 4,557,740 | $72,878,000 | 0.77% |
| DIALECTIC CAPITAL MANAGEMENT, LP | 79,550 | $1,272,000 | 0.60% |